Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
Meningococcal disease
NITAG documentation
SAGE documentation
2015
Clear all
Type of publications
NITAG documentation
(9)
SAGE documentation
(5)
Scientific publications
(2)
Systematic reviews (SYSVAC)
(3)
Topics
Background paper
(3)
GRADE table
(4)
Recommendation
(6)
Regions
Americas
(5)
Europe
(4)
Countries
Canada
(1)
France
(1)
Germany
(1)
Switzerland
(2)
United States of America
(4)
Diseases
Meningococcal disease
(14)
Diphtheria
(1)
Haemophilus influenzae type B
(3)
Hepatitis A
(4)
Hepatitis B
(3)
Human papillomavirus (HPV)
(17)
Japanese encephalitis
(10)
Malaria
(1)
Measles
(3)
Pertussis
(8)
Pneumococcal disease
(5)
Poliomyelitis
(1)
Rotavirus
(2)
Typhoid
(1)
Yellow fever
(4)
Publication date
2015
(14)
2024
(1)
2023
(2)
2022
(1)
2020
(1)
2019
(13)
2018
(12)
2017
(4)
2016
(12)
2014
(13)
2013
(5)
2011
(5)
2010
(5)
2009
(2)
2008
(1)
2007
(2)
2006
(5)
2005
(1)
2001
(1)
2000
(1)
1997
(1)
Target population
Newborn
(3)
Available to download in languages
English (EN)
(11)
French (FR)
(4)
14 results found
2015
∙
STIKO
Background Paper for the update of meningococcal vaccination recommendations in Germany: use of the serogroup B vaccine in persons at increased risk for meningococcal disease
2015
∙
WHO
Meningococcal A conjugate vaccine: updated guidance
2015
∙
SAGE
Duration of protection conferred by MenA conjugate vaccination in immunocompetent children (3 to 24 months of age) against serogroup A meningococcal disease
2015
∙
SAGE
Efficacy of a single-dose MenA conjugate vaccination in immunocompetent children (9 to 24 months of age) against serogroup A meningococcal disease
2015
∙
SAGE
Efficacy of a two dose schedule of MenA conjugate vaccination in immunocompetent children (3 to 9 months of age) against serogroup A meningococcal disease
2015
∙
SAGE
Safety of MenA conjugate vaccination in immunocompetent children (3 to 24 months of age)
2015
∙
ACIP
Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) for Use of Serogroup B Meningococcal (MenB) Vaccines in Adolescents and Young Adults (Including College Students)
2015
∙
NACI
Update on Quadrivalent Meningococcal Vaccines available in Canada
2015
∙
Jessica MacNeil
Considerations for Use of Serogroup B Meningococcal (MenB) Vaccines in Persons at Increased Risk
2015
∙
Haut Conseil de la santé publique
Notice relating to the immunisation recommendations against invasive meningococcal C infections after 24 years, notably in men who have sex with other men (MSM)
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register